Jump to content

TC-1698: Difference between revisions

Content deleted Content added
CheMoBot (talk | contribs)
Updating {{drugbox}} (no changed fields - updated 'ChemSpiderID_Ref', 'DrugBank_Ref', 'UNII_Ref', 'ChEMBL_Ref', 'ChEBI_Ref', 'KEGG_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref', 'ChEBI_Ref') per Chem/Drugbox validation (report [[Wikipedia
Open access status updates in citations with OAbot #oabot
 
(17 intermediate revisions by 16 users not shown)
Line 1: Line 1:
{{Short description|Chemical compound}}
{{Drugbox| verifiedrevid = 349891046
{{Drugbox
|
| Verifiedfields = changed
|IUPAC_name = 2-pyridin-3-yl-1-azabicyclo[3.2.2]nonane
| verifiedrevid =
| image=TC-1698_structure.png
|IUPAC_name = 2-pyridin-3-yl-1-azabicyclo[3.2.2]nonane
| width= 240
| image = TC-1698.svg
| CAS_number=
| width=
| ATC_prefix=

| ATC_suffix=
<!--Clinical data-->
| PubChem= 10130417
| tradename =
| legal_status = Legal
| routes_of_administration

<!--Identifiers-->
| CAS_number=
| ATC_suffix=
| PubChem= 10130417
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = 8305933
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| DrugBank=
| C=13 | H=18 | N=2
| =

| molecular_weight = 202.295
<!--Chemical data-->
| C=13 | H=18 | N=2
| smiles = c2ncccc2C1CCC3CCN1CC3
| smiles = c2ncccc2C1CCC3CCN1CC3
| StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| bioavailability=
| StdInChI = 1S/C13H18N2/c1-2-12(10-14-7-1)13-4-3-11-5-8-15(13)9-6-11/h1-2,7,10-11,13H,3-6,8-9H2
| metabolism =
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| elimination_half-life=
| StdInChIKey = WIEWCOLOPGXZDJ-UHFFFAOYSA-N
| excretion =
| pregnancy_category =
| legal_status = Legal
| routes_of_administration=
}}
}}


'''TC-1698''' is a drug developed by [[Targacept]] which acts as a [[partial agonist]] for the [[Alpha-7 nicotinic receptor|α7]] subtype of neural [[nicotinic acetylcholine receptor]]s.<ref>{{Cite pmid|17295372}}</ref> It has [[neuroprotective]] effects in animal studies,<ref>{{Cite pmid|14722323}}</ref> and has been used as a [[lead compound]] to find further potent derivatives.<ref>{{Cite pmid|18363376}}</ref>
'''TC-1698''' is a drug developed by [[Targacept]] which acts as a [[partial agonist]] for the [[Alpha-7 nicotinic receptor|α7]] subtype of neural [[nicotinic acetylcholine receptor]]s.<ref>{{ |17295372}}</ref> It has [[neuroprotective]] effects in animal studies,<ref>{{ |14722323}}</ref> and has been used as a [[lead compound]] to find further potent derivatives.<ref>{{ |18363376}}</ref>

==See also==
* [[Anabasine]]


== References ==
== References ==
{{Reflist|2}}
{{Reflist|2}}



{{Stimulants}}
{{Stimulants}}
{{Nootropics}}
{{Cholinergics}}



{{Nicotinic acetylcholine receptor modulators}}


[[Category:Nicotinic agonists]]
[[Category:Nicotinic agonists]]
[[Category:Stimulants]]
[[Category:Stimulants]]
[[Category:Pyridines]]
[[Category:]]